BSCAX
Price
$23.87
Change
-$0.05 (-0.21%)
Updated
Jul 13 closing price
Net Assets
639.81M
SSGSX
Price
$52.87
Change
-$0.12 (-0.23%)
Updated
Jul 13 closing price
Net Assets
4.55B
Interact to see
Advertisement

BSCAX vs SSGSX

BSCAX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
BSCAX vs. SSGSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSCAX is a Buy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.55B vs. BSCAX (640M). SSGSX pays higher dividends than BSCAX: SSGSX (0.51) vs BSCAX (0.39). BSCAX was incepted earlier than SSGSX: BSCAX (9 years) vs SSGSX (27 years). SSGSX (1.23) and BSCAX (1.21) have similar cost to investors . SSGSX is a more actively managed with annual turnover of: 50.00 vs. BSCAX (30.28). BSCAX (6%) and SSGSX (6%) have equivalent initial investment costs. BSCAX (2500) and SSGSX (2500) have matching initial minimum investment requirements. BSCAX annual gain was more profitable for investors over the last year : 33.82 vs. SSGSX (17.30). BSCAX return over 5 years is better than : 93.81 vs. SSGSX (-0.56).
BSCAXSSGSXBSCAX / SSGSX
Total Expense Ratio1.161.2394%
Annual Report Gross Expense Ratio1.211.2398%
Fund Existence9 years27 years-
Gain YTD21.43118.572115%
Front Load6%6%100%
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets640M4.55B14%
Annual Yield % from dividends0.390.5177%
Returns for 1 year33.8217.30195%
Returns for 3 years85.5011.95716%
Returns for 5 years93.81-0.56-16,869%
Returns for 10 yearsN/A41.05-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJMSX15.77N/A
N/A
VY® JPMorgan Mid Cap Value S
RSNYX67.09N/A
N/A
Victory Global Energy Transition Y
IUERX32.35N/A
N/A
JPMorgan International Focus R2
AFOCX25.98N/A
N/A
Archer Focus
JNGLX88.37-0.69
-0.77%
Janus Henderson Global Life Sciences D